ShanghaiTech University Knowledge Management System
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling | |
Gao, Hong1; Yin, Fen-Fen1,2; Guan, Dong-Xian1; Feng, Yu-Xiong1; Zheng, Qian-Wen3 ![]() ![]() | |
2019-05 | |
发表期刊 | CELL PROLIFERATION
![]() |
ISSN | 0960-7722 |
卷号 | 52期号:3 |
发表状态 | 已发表 |
DOI | 10.1111/cpr.12583 |
摘要 | Objectives Wnt1-inducible signalling pathway protein 3 (WISP3/CCN6) belongs to the CCN (CYR61/CTGF/NOV) family of proteins, dysregulation of this family contributed to the tumorigenicity of various tumours. In this study, we need to explore its role in hepatocellular carcinoma that remains largely elusive. Materials and Methods The expression of WISP3/CCN6 was analysed by qRT-PCR and Western blotting. Effects of WISP3 on proliferation and metastasis of HCC cells were examined, respectively, by MTT assay and Boyden Chamber. Roles of WISP3 on HCC tumour growth and metastatic ability in vivo were detected in nude mice. Related mechanism study was confirmed by immunofluorescence and Western blotting. Results The expression of WISP3 was significantly downregulated in HCC clinical samples and cell lines, and reversely correlated with the tumour size. Forced expression of WISP3 in HCC cells significantly suppressed cell growth and migration in vitro as well as tumour growth and metastatic seeding in vivo. In contrast, downregulation of WISP3 accelerated cell proliferation and migration, and promoted in vivo metastasis. Further study revealed that WISP3 inhibited the translocation of beta-catenin to the nucleus by activating glycogen synthase kinase-3 beta (GSK3 beta). Moreover, constitutively active beta-catenin blocked the suppressive effects of WISP3 on HCC. Conclusions Our study showed that WISP3 suppressed the progression of HCC by negative regulation of beta-catenin/TCF/LEF signalling, providing WISP3 as a potential therapeutic candidate for HCC. |
关键词 | hepatocellular carcinoma metastasis tumorigenesis WISP3 beta-catenin |
收录类别 | SCI ; SCIE |
语种 | 英语 |
资助项目 | National Natural Science Foundation of China[31520103907] ; National Natural Science Foundation of China[81730083] ; National Natural Science Foundation of China[31771538] ; National Natural Science Foundation of China[31601143] |
WOS研究方向 | Cell Biology |
WOS类目 | Cell Biology |
WOS记录号 | WOS:000469271700015 |
出版者 | WILEY |
WOS关键词 | CCN FAMILY ; E-CADHERIN ; COLORECTAL CARCINOMAS ; WNT PATHWAY ; CATENIN ; PROLIFERATION ; EXPRESSION ; GROWTH ; CELLS ; GENE |
原始文献类型 | Article |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/45615 |
专题 | 生命科学与技术学院_特聘教授组_谢东组 生命科学与技术学院_硕士生 |
通讯作者 | Li, Jing-Jing; Xie, Dong |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China 2.Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai, Peoples R China 3.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 4.Huzhou Univ, Peoples Hosp 1, Dept Surg, Huzhou, Peoples R China 5.Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai, Peoples R China 6.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China 7.China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing, Peoples R China |
通讯作者单位 | 生命科学与技术学院 |
推荐引用方式 GB/T 7714 | Gao, Hong,Yin, Fen-Fen,Guan, Dong-Xian,et al. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling[J]. CELL PROLIFERATION,2019,52(3). |
APA | Gao, Hong.,Yin, Fen-Fen.,Guan, Dong-Xian.,Feng, Yu-Xiong.,Zheng, Qian-Wen.,...&Xie, Dong.(2019).Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling.CELL PROLIFERATION,52(3). |
MLA | Gao, Hong,et al."Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling".CELL PROLIFERATION 52.3(2019). |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。